Skip to content

Peritubal Infiltration of Bupivacaine in PCNL

Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02198027
Enrollment
68
Registered
2014-07-23
Start date
2014-07-31
Completion date
2014-12-31
Last updated
2014-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Percutaneous nephrolithotomy, postoperative analgesia, peritubal block, pain, Visual Analog Pain Scale

Brief summary

Patients may feel significant pain at the surgery site after they wake up from the surgery. Usually pain is managed in the ward by giving strong pain medication that may slow down your mobilization and recovery process. Some recent work in other countries has shown that if investigator give patients an injection at the end of the operation, patients have less need for pain medication when they wake up. If investigator find that is also true in our population, then we can use this method as routine step after this operation to improve pain management and early mobilization of our patients

Interventions

DRUGBupivacaine

23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of 0.25 % Bupivacaine into renal capsule to skin.

OTHERNormal saline infiltration

23 G spinal needle will be introduced along the nephrostomy tube for peri-tubal infiltration of 10 ml of normal saline into renal capsule to skin

Sponsors

Indus Hospital and Health Network
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-60 years of age * Single PCNL track

Exclusion criteria

* Spinal Disc Prolapse * Any previous renal surgery * Complication secondary to PCNL * Hydrothorax that requires intervention * Pneumothorax * Massive hemorrhage that requires more than 1 U transfusion * Conversion to open procedure.

Design outcomes

Primary

MeasureTime frameDescription
Mean time for first demand of rescue analgesicRelease of the patient from the hospital or 24 hours (whichever comes first)Mean time for first demand defined as the difference in time between the first time rescue medications is given to patient in post-operatively and the time the infiltration took place intra-operatively

Countries

Pakistan

Contacts

Primary ContactZeeshan Arshad, MBBS
zeeshandaa@hotmail.com
Backup ContactNaila Baig-Ansari, PhD
naila.baig.ansari@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026